Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

June 19, 2025

Primary Completion Date

December 21, 2025

Study Completion Date

January 25, 2026

Conditions

HIVInsomniaAnxiety

Interventions

DRUG

Dolutegravir (DTG)

Dolutegravir + Tenofovir Disoproxil Fumarate / Emtricitabine

DRUG

Darunavir/Cobicistat (FDC)

Darunavir Cobicistat + TDF/FTC

All Listed Sponsors

lead

Instituto Mexicano del Seguro Social

OTHER_GOV